ASHLAND, Ohio & DEN BOSCH, Netherlands--(BUSINESS WIRE)--WIL Research, a leading global Contract Research Organization (CRO) in the pharmaceutical, chemical and agrochemical industries, today announced the opening of a new safety assessment facility in Schaijk, Netherlands. In response to the increasing demand for outsourced safety assessment and services, the Schaijk site, located 18km (approximately 11 miles) from WIL Research’s main Netherlands site in Den Bosch, offers a modern, state-of-the-art facility built upon a former pharmaceutical company laboratory.
In efforts to support the rapid increase in demand from chemical, agrochemical and pharmaceutical clients, WIL Research attained the new site to allow for additional high-quality capacity, study management and an enhanced reporting turnaround time.
“Our number one priority is to arm our clients with the vital information and resources needed to progress,” said Wilbert Frieling, D.V.M., senior vice president of European Operations. “With increases in both toxicology and analytical services capacity, and leveraging our significant experience in Den Bosch, we can offer our clients more rapid study starts and reporting timelines. The addition of the Schaijk location enhances a strong center of excellence here in The Netherlands serving both global and local clients.”
WIL Research now has approximately 1,400 staff worldwide with laboratories in the United States and Europe and sales and regulatory support in Asia. For more information about WIL Research, please visit www.wilresearch.com.
About WIL Research
WIL Research is an interdisciplinary non-clinical contract research organization providing product safety and toxicological assessment research and services to the international pharmaceutical, biotechnology, chemical, agricultural, veterinary, food and consumer products industries.
Find out more about WIL Research at www.wilresearch.com.
